Hospira, Inc. (HSP) Tops Q1 EPS by 11c

Hospira, Inc. (NYSE: HSP) reported Q1 EPS of $0.60, $0.11 better than the analyst estimate of $0.49. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.02 billion.

"Hospira generated stronger-than-expected first-quarter results, starting the year off on a positive note," said F. Michael Ball, chief executive officer. "Our performance underscores the value of our strategy and the investments we have been making to reinforce our foundation and drive growth. As we mark Hospira's 10-year anniversary as an independent company, we remain committed to advancing wellness around the world, and are well positioned to build on the many achievements of our first decade, with a focus on driving profitable growth and shareholder value."

For earnings history and earnings-related data on Hospira, Inc. (HSP) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance